Allgaier C.
56
Coauthors
7
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Neurología | 7 |
| Neuropsicología | 4 |
| Biología celular | 2 |
| Apoptosis | 1 |
| Bioquímica | 1 |
| Farmacología | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 6 |
| Fisiología humana | 5 |
| Farmacología y terapéutica | 3 |
| Sistemas fisiológicos específicos de los animales | 3 |
| Medicina y salud | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 7 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Pallás M. | 7 |
| Verdaguer E. | 7 |
| Antoni Camins | 7 |
| Garcia De Arriba S. | 4 |
| Jiménez A. | 3 |
| Jordá E.G. | 2 |
| Canudas A.M. | 2 |
| de Arriba S.G. | 2 |
| Alvira D. | 2 |
| Münch G. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Evaluation of the neuronal apoptotic pathways involved in cytoskeletal disruption-induced apoptosis
ArticleAbstract: The cytoskeleton is critical to neuronal functioning and survival. Cytoskeletal alterations are invoPalabras claves:calcium, Calpainsl, Caspases, Cytoskeleton, Serine-proteasesAutores:Allgaier C., Antoni Camins, Arriba S.G.D., Jiménez A., Jordá E.G., Pallás M., Verdaguer E.Fuentes:scopusImplication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium
ArticleAbstract: Although numerous studies have demonstrated a neuroprotective and anti-apoptotic role of lithium inPalabras claves:apoptosis, Cdk5/p25, Cerebellar granule neurons, GSK-3β, LithiumAutores:Allgaier C., Antoni Camins, Canudas A.M., Garcia De Arriba S., Jiménez A., Jordá E.G., Pallás M., Verdaguer E.Fuentes:scopusInhibitors of cyclin-dependent kinases: Potential drugs for the treatment of neurodegenerative disorders?
ReviewAbstract: The pharmacological treatment of neurodegenerative disorders such as Alzheimer's disease, Parkinson'Palabras claves:Autores:Allgaier C., Alvira D., Antoni Camins, Canudas A.M., Garcia De Arriba S., Pallás M., Sureda F.X., Verdaguer E.Fuentes:scopusDifferent capacities of various NMDA receptor antagonists to prevent ischemia-induced neurodegeneration in human cultured NT2 neurons
ArticleAbstract: In the present study, human NT2 neurons obtained from embryonic teratocarcinoma (NT2) cells were estPalabras claves:Cultured human NT2 neurons, Glycine binding site antagonists B, immunocytochemistry, ischemia, NMDA receptors, Patch-clamp recordingsAutores:Allgaier C., Antoni Camins, Garcia De Arriba S., Grüner K., Pallás M., Verdaguer E., Wagner A., Wegner F., Wohlfahrt K.Fuentes:scopusNeuroprotection associated with alternative splicing of NMDA receptors in rat cortical neurons
ArticleAbstract: 1 Exposure of cultured cortical neurons to elevated extracellular K + concentrations (25 mM) inducesPalabras claves:Calpain, Caspase-3, Cultured cortical neurons, neuroprotection, NMDA receptors, Receptor adaptationAutores:Allgaier C., Antoni Camins, de Arriba S.G., Jaekel B., Mühlberg K., Nörenberg W., Pallás M., Reichenbach A., Verdaguer E.Fuentes:scopus